预防复发性中风的最佳抗血小板药物是什么？
What is better antiplatelet agent to prevent recurrent stroke?
作者信息
Wadiwala Muhammad Faisal, Kamal Ayeesha Kamran
机构信息
Stroke Service and Vascular Fellowship Program, International Cerebrovascular Translational Clinical Research Training Program (Fogarty International Center and National Institute of Neurologic Disorders and Stroke), Aga Khan University Hospital, Karachi, Pakistan.
出版信息
J Pak Med Assoc. 2012 Sep;62(9):976-7.
Abstract
Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent StrokePrevention Regimen for Effectively Avoiding Second Strokes(PRoFESS) Study Group.
摘要
阿司匹林与缓释双嘧达莫对比氯吡格雷预防复发性卒中有效避免二次卒中方案（PRoFESS）研究组
相似文献
1
What is better antiplatelet agent to prevent recurrent stroke?
J Pak Med Assoc. 2012 Sep;62(9):976-7.
2
Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
Cerebrovasc Dis. 2007;23(5-6):368-80. doi: 10.1159/000100105. Epub 2007 Feb 26.
3
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
N Engl J Med. 2008 Sep 18;359(12):1238-51. doi: 10.1056/NEJMoa0805002. Epub 2008 Aug 27.
4
The PRoFESS trial: future impact on secondary stroke prevention.
Expert Rev Neurother. 2007 Sep;7(9):1085-91. doi: 10.1586/14737175.7.9.1085.
5
[PRoFESS study presented. Change in secondary prevention].
MMW Fortschr Med. 2003 May 26;145 Suppl 2:96-7.
6
Use of antiplatelet agents to prevent stroke: what is the role for combinations of medications?
Curr Neurol Neurosci Rep. 2008 Jan;8(1):29-34. doi: 10.1007/s11910-008-0006-1.
7
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.
Lancet Neurol. 2008 Oct;7(10):875-84. doi: 10.1016/S1474-4422(08)70198-4. Epub 2008 Aug 29.
8
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
N Engl J Med. 2018 Jul 19;379(3):215-225. doi: 10.1056/NEJMoa1800410. Epub 2018 May 16.
9
What is the best first agent to give to a patient with acute ischaemic stroke? Aspirin, heparin, clopidogrel, cilostazol or dipyridamole?
J Pak Med Assoc. 2010 Oct;60(10):877-8.
10
Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
J Neurol Sci. 2009 Sep 15;284(1-2):1-9. doi: 10.1016/j.jns.2009.04.001. Epub 2009 Apr 19.
引用本文的文献
1
The Role of Sartans in the Treatment of Stroke and Subarachnoid Hemorrhage: A Narrative Review of Preclinical and Clinical Studies.
Brain Sci. 2020 Mar 7;10(3):153. doi: 10.3390/brainsci10030153.
本文引用的文献
1
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
N Engl J Med. 2008 Sep 18;359(12):1238-51. doi: 10.1056/NEJMoa0805002. Epub 2008 Aug 27.
Zotero 插件